Skip to search formSkip to main contentSkip to account menu

Vulvovaginal atrophy

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Vaginal laser therapy is a non-hormonal treatment option for vulvovaginal atrophy (VVA), a component of the genitourinary… 
2017
2017
Abstract Objective: Serum concentrations of estradiol (E2) and testosterone (testo) measured by mass spectrometry-based assays… 
2017
2017
Objective: The aim of the study was to determine the range of serum sex-related steroids in normal postmenopausal women and in… 
Review
2017
Review
2017
In 2015, we published an editorial in the International Urogynecology Journal on laser vaginal rejuvenation [1]. We questioned… 
2017
2017
1221 NAMS 3rd Utian Translational Science Symposium, October 2016, Orlando, Florida A conversation about hormone therapy: is… 
Review
2014
Review
2014
Objective: To review the pharmacology, efficacy, and safety of ospemifene in the management of dyspareunia. Data Sources… 
Review
2014
Review
2014
Declining estrogen levels associated with menopause can result in vulvovaginal atrophy and some degree of dyspareunia for more… 
2011
2011
Mrs. K is a 67-year-old woman presenting for a brief follow-up visit. You treated her for an E. coli urinary tract infection last… 
Review
2001